Lower riskMedical device recall · FDA · Published March 29, 2022
Philips CT scanner recall: Software issues may cause incorrect image display
Philips recalls certain CT scanners due to software issues that may cause incorrect image display, error interpreting patient images, and patient exposure to incorrect image/function during clinical use.
Three software issues affecting incorrect image display, error interpreting patient images due to image reporting, and patient exposure to incorrect image/function during clinical use.
Take action
Contact the company
📍Recalling firmPhilips North America Llc222 Jacobs St · Cambridge, MA 02141-2289
✎ GovInfoNow plain-language explainer
Philips is recalling certain whole-body CT scanners that have software issues causing incorrect image display, error interpreting patient images, and potential patient exposure to incorrect image/function during clinical use. This could lead to misdiagnosis or improper treatment if the scanner is used without correction. Read more at govinfonow.com/recall/60883-philips-ct-scanner-recall-software-issues-may-cause-incorrect-image.
“Philips CT scanner recall: Software issues may cause incorrect image display.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60883-philips-ct-scanner-recall-software-issues-may-cause-incorrect-image. Based on FDA recall #Z-0576-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0576-2024%22&limit=1).
The U.S. Food and Drug Administration (FDA) has issued a voluntary recall for Philips whole-body CT x-ray systems due to potential safety hazards.
How to tell if you have it
Philips North America Llc
whole-body CT x-ray system
The hazard
The provided text lists hazards associated with other recent recalls by Philips North America Llc, including software issues terminating examinations, extra radiation exposure from Bolus tracking crashes, unintended radiation risks with IQon/iCT/Ingenuity/Brilliance CT systems, unstable sensors causing incomplete scans, bolus tracking failures, and software errors potentially causing wrong patient diagnosis.
Context
This recall involves 330 units distributed domestically in AL, AR, AZ, CA, FL, GA, HI, IL, IN, KY, LA, MD, ME, MI, MS, NC, NJ, NM, NY, OH, OK, PA, RI, TN, TX and internationally in Albania, Argentina, Australia, Austria, Bolivia, Bosnia-Herzegovina, Cambodia, Canada, Chile, Colombia, Costa Rica, Czech Republic, Ecuador, Egypt, Ethiopia, France, Germany, Greece, Hong Kong, Hungary, India, Israel, Italy, Japan, Kenya, Kosovo, Lao People's Democratic Republic, Latvia, Lebanon, Moldova, Morocco, Netherlands, Palestine, Panama, Paraguay, Peru, Poland, Portugal, Romania, Russian Federation, Saint Lucia, Saint Pierre and Miquelon, Sint Maarten, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom, and Viet Nam. Philips North America Llc has 129 other recalls on record since 2017-07-12.
How to tell if you have this one
Check for system codes 728143 or 728144 on the scanner. The equipment numbers listed in the recall include specific serial numbers and model identifiers that can be found on the device or in the documentation.
Brand
Philips
Product
The device is a whole-body CT x-ray system. The acquired x-ray transmission data is reconstructed by computer into
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Contact Philips
Reach out to Philips customer support to confirm if your scanner is affected and get instructions for correction.
Where it went and when
Where it was distributed
Distributed in 25 states, and outside the U.S.
Listed by the agency
Not listed
FDA distribution: “Domestic: AL, AR, AZ, CA, FL, GA, HI, IL, IN, KY, LA, MD, ME, MI, MS, NC, NJ, NM, NY, OH, OK, PA, RI, TN, TX; Foreign: Albania, Argentina, Australia, Austria, Bolivia, Bosnia-Herzegovina , Cambodia, Canada, Chile, Colombia, Costa Rica,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama, Arizona, Arkansas, California, Florida, Georgia, Hawaii, Illinois, Indiana, Kentucky, Louisiana, Maine, Maryland, Michigan, Mississippi, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Texas.
Recall timeline
FDA published this recall 21 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0576-2024 (March 29, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0576-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.